APUS AMEX
Apimeds Pharmaceuticals US, Inc
1W: -55.6%
1M: +22.4%
3M: -62.6%
YTD: -80.7%
1Y: -81.2%
$3.22
-0.88 (-21.46%)
Weekly Expected Move ±68.6%
$-1
$1
$3
$5
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
No Supply Chain Data
No business relationships found for APUS in SEC 8-K filings.
This may mean the company hasn't filed material agreements or acquisitions in the covered period (2021–2026), or the company may not have a CIK-to-ticker mapping.